Cirrhosis, familial
MONDO:0007329Cirrhosis in which no causative agent can be identified.
Also known as: cirrhosis, familial, cryptogenic cirrhosis, hereditary cirrhosis of liver, Indian childhood cirrhosis, Sen syndrome, cirrhosis, Noncryptogenic, susceptibility to, cirrhosis, cryptogenic, cirrhosis, familial, with pulmonary hypertension
82 clinical trials for this condition and its sub-types, 4 tagged with Cirrhosis, familial itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Cirrhosis, familial
-
Primary biliary cholangitis 74 trials
5 sub-types
- Primary biliary cholangitis 1 3 trials
- Primary biliary cholangitis 2 0 trials
- Primary biliary cholangitis 3 0 trials
- Primary biliary cholangitis 4 0 trials
- Primary biliary cholangitis 5 0 trials
-
Isolated congenital hepatic fibrosis 2 trials
-
New combo therapy aimed at Hard-to-Treat liver disease
Disease control Stopped earlyThis study tested whether combining two drugs, obeticholic acid and bezafibrate, could improve liver health in people with primary biliary cholangitis (PBC) who did not respond well to or could not take the standard medicine. The trial enrolled 75 adults and measured changes in a…
Phase 2 • Sponsor: Intercept Pharmaceuticals • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
PBC drug combo safety check ends early
Disease control Stopped earlyThis study looked at the long-term safety of a fixed-dose combination of two drugs (obeticholic acid and bezafibrate) for people with primary biliary cholangitis (PBC), a chronic liver disease. It enrolled 62 adults who had already been taking the combination in earlier studies. …
Phase 3 • Sponsor: Intercept Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Blood test may tame the tightrope walk of transplant drugs
Diagnosis Stopped earlyThis study tests whether a blood test called TruGraf can help doctors fine-tune immunosuppression medications in liver transplant recipients with autoimmune liver diseases like autoimmune hepatitis, primary sclerosing cholangitis, or primary biliary cirrhosis. The test measures g…
Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC
-
Ear device aims to cut opioid use after liver transplant
Symptom relief Stopped earlyThis study tested a small device worn on the ear that uses mild electrical pulses to help control pain after a liver transplant. The goal was to see if it could reduce the need for strong painkillers like opioids. The study was stopped early and included 27 adults waiting for a l…
Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC